If you're reading this, chances are you're a builder — a founder, technologist, or product leader who's caught the healthcare bug. Maybe you're transitioning from another industry, maybe you're fresh out of a fellowship or lab, or maybe you've had a personal encounter with the system's many inefficiencies. Either way, welcome. You're stepping into one of the most complex, slow-moving, yet opportunity-rich sectors on the planet.
I've been where you are. At Althea, we build AI agents to automate and streamline patient engagement and workflows across the healthcare stack. But before I got into it, I thought "healthcare" was just doctors, patients, and insurers. Now I know better.
If you want to sell into healthcare, or build for it, you need to understand the ecosystem. So in this guide, I'll walk you through the major players, what makes them tick, what makes them stall, and how to set expectations when you're trying to do business with them.
First, who's in the game?
Healthcare is not one system. It's an overlapping mesh of stakeholders, each with its own incentives, power dynamics, procurement cycles, and budget structures. Let's break it down.
1. Patients (aka "members," "consumers," or "beneficiaries"). The people receiving care or coverage. They're often the user but rarely the buyer, and they're not monolithic — think commercial vs. Medicare vs. Medicaid populations. Pro tip: B2C models in healthcare are hard unless you have consumer pull or urgent need (e.g. mental health, fertility, or weight loss apps).
2. Sponsors (aka payers of premiums). Employers, government (Medicare, Medicaid), unions. These are the entities that finance healthcare, either through group coverage or public programs. They indirectly control cost and quality levers and often contract with insurers or administrators.
3. Insurers (aka payers). Commercial plans (e.g., UnitedHealthcare, Aetna), Blues, Medicaid MCOs, Medicare Advantage plans. Power is very high — they manage risk pools, coverage decisions, and increasingly care delivery. Sales cycle: 12–24 months, budgeted annually. They're hard to penetrate, super conservative, and deeply bureaucratic. Entry is often through pilots, care management orgs, or aligned provider groups.
4. Healthcare Delivery (aka providers). Health systems (e.g. Kaiser, HCA), independent hospitals, medical groups, FQHCs, private equity roll-ups. Buying behavior depends on size and type: systems = slow, groups = faster, PE-backed = ROI-focused. Expect EHR integration (Epic, Cerner, Athena), sometimes CRM (Salesforce), and increasingly data warehousing (Snowflake, Redox). Watch out: "innovation" may mean very different things depending on whether they're risk-bearing or fee-for-service.
Adjacent ecosystem players
Here's where things get interesting. These aren't always household names, but they drive serious value and influence.
a. Pharmacy Benefit Managers (PBMs) — e.g. CVS Caremark, Express Scripts. Power brokers between drug manufacturers, pharmacies, and health plans, known for opaque pricing models, rebates, and gatekeeping formularies. In plain terms: formularies = approved drug lists that dictate coverage and cost.
b. Third-Party Administrators (TPAs) — especially in self-funded employer plans. They handle claims and benefits for employers and can be more flexible than traditional payers.
c. Brokers and Benefits Consultants — Aon, Mercer, smaller firms. They influence what employers buy. If you're selling to employer-sponsored plans, you'll need these folks on your side.
d. Pharma — traditional and biotech. Deep budgets and long R&D cycles, increasingly investing in digital health for companion apps, real-world evidence, adherence, and more.
e. Government & Non-Profits — CMS, CDC, health departments. Huge potential for scale, but often grant-based, cyclical, and compliance-heavy.
Doing business with healthcare stakeholders
Let's talk real talk. Each player comes with its own pros, cons, and mindset:
- Health Systems — Pros: data access, brand validation. Cons: long sales cycles, EHR integration hell. Expect 9–18 months, governance heavy.
- Medical Groups — Pros: faster decision-making. Cons: less budget, fragmented IT. Expect 3–6 months, may lack data ops.
- Payers — Pros: huge scale, long-term value. Cons: byzantine orgs, regulatory barriers. Start with pilots; look for care gaps or STARS levers.
- Employers — Pros: clear ROI thinking, top-down mandates. Cons: must navigate brokers/consultants. Sell to benefits leaders; data = king.
- Pharma — Pros: high budgets, patient reach. Cons: slow cycles, rigid compliance. Start with brand or medical teams.
- PBMs/TPAs — Pros: control over pricing and access. Cons: black-box economics. You'll need inside champions.
The sales cycle, budgeting & procurement realities
One of the most painful learnings for first-time founders: healthcare sales are slow. Here's why:
- Annual budgeting cycles (especially for payers and systems).
- IT reviews and "security assessments."
- Legal/compliance hurdles (HIPAA, SOC 2, BAAs).
- Clinical validation expectations (evidence-based, often requiring studies or pilots).
For most enterprise buyers, expect a path of Discovery → Championing → Pilot → Expansion over 12–24 months. Contracting timelines can add 3–6 months on top. And budget is often tied to a fiscal calendar — miss that window, and you wait another year.
Integrations: the hidden tax
You're going to hear these acronyms a lot:
- EHR (Electronic Health Record) — Epic, Cerner, Athena.
- CRM — increasingly Salesforce for call centers and marketing.
- EPR (Enterprise Patient Record or Research) — sometimes overlaps with EHR.
- HIEs, FHIR, HL7, SFTP — your new favorite acronyms.
Reality check: integration is rarely turnkey. Expect high variability across clients, even if they use the same EHR vendor. We built Althea to minimize this pain by abstracting and automating integrations where possible — but many teams get stuck here for months.
AI readiness and appetite for innovation
Is healthcare slow? Yes. But is it anti-innovation? Not quite. It's just risk-averse — for good reason. Lives are on the line.
That said, AI is gaining serious traction, especially where labor shortages are hitting (call centers, documentation, prior auth), where STARS measures, HEDIS, and other quality metrics are tied to reimbursement, and where operational inefficiencies can be addressed without touching the clinical workflow.
We've seen the fastest adoption in population health, clinical documentation, patient engagement, and revenue cycle automation. Pro tip: if you can prove ROI in dollars saved, staff time reduced, or improved quality measures, you'll get traction.
Compliance, regulation, and the bureaucracy beast
You're going to need:
- HIPAA compliance (obviously).
- BAA agreements for any PHI handling.
- SOC 2 Type II for most enterprise deals.
- FDA clearance if you're touching diagnostics, predictions, or treatment decisions.
Good legal counsel here is not optional. Build compliance into your architecture early. Your future self will thank you.
Quick summary: your startup playbook
If I had to summarize what you need to keep in mind:
- Learn the landscape — it's a web, not a hierarchy.
- Pick your buyer — and learn their budget and pain points.
- Know your sales cycle — 6–24 months is normal.
- Plan for integration pain — especially with EHRs.
- Start small, prove ROI — land-and-expand is your friend.
- Invest in compliance early — don't hack it later.
If you're building in this space, or considering it, reach out. We love swapping notes and helping other founders navigate the maze.